Justices appear skeptical of arguments against mifepristone as pharmaceutical industry considers case existential threat
Supreme court justices seemed to express skepticism towards arguments by a group of anti-abortion doctors in a case that could reshape the availability of medication abortion and undermine the US Food and Drug Administration’s (FDA) authority.
The supreme court heard oral arguments on Tuesday in Alliance for Hippocratic Medicine v FDA, the first abortion case to reach the supreme court since it overturned Roe v Wade almost two years ago.
